SONA Asset Management (US)’s Tevogen Bio Holdings TVGN Stock Holding History

SONA Asset Management (US)’s Portfolio TVGN Stock Details TVGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-300	Closed	-$155K	–	179
2022 Q4	$155K	Hold	300	–	–	0.04%	100
2022 Q3	$152K	Hold	300	–	–	0.09%	124
2022 Q2	$150K	Buy	+300	New	+$150K	0.15%	119

Other funds holding TVGN

CCP

Corbin Capital Partners New York $61.3M AUM 53.03% 1-Year Est. Return

FCM

FourWorld Capital Management New York $196M AUM 42.39% 1-Year Est. Return

Cantor Fitzgerald New York $6.78B AUM 29.01% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

SONA Asset Management (US)'s TVGN Position: Q1 2023 in Review

SONA Asset Management (US) sold out of Tevogen Bio Holdings (TVGN) in Q1 2023, closing a stake of 300 shares — an estimated $155K sold.

SONA Asset Management (US) first reported a position in TVGN in Q2 2022 and held it in 3 quarters. The position peaked at $155K in Q4 2022. 4 funds tracked by Wall St. Rank hold TVGN as of Q1 2023.

SONA Asset Management (US) reported no remaining Tevogen Bio Holdings position as of Q1 2023 after selling out during the quarter.
SONA Asset Management (US) sold 300 Tevogen Bio Holdings shares in Q1 2023, an estimated $155K.
SONA Asset Management (US) first reported a position in Tevogen Bio Holdings in Q2 2022 and held it in 3 quarters.
SONA Asset Management (US)'s Tevogen Bio Holdings position peaked at $155K in Q4 2022.
4 funds tracked by Wall St. Rank held Tevogen Bio Holdings as of Q1 2023.

Based on SONA Asset Management (US)'s 13F filing for Q1 2023, filed 15 May 2023.